↓ Skip to main content

Cochrane Database of Systematic Reviews

SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19

Overview of attention for article published in Cochrane database of systematic reviews, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
2 news outlets
blogs
4 blogs
twitter
292 tweeters
facebook
3 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
168 Mendeley
Title
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Published in
Cochrane database of systematic reviews, September 2021
DOI 10.1002/14651858.cd013825.pub2
Pubmed ID
Authors

Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, Eve Tomlinson, Zahra Khosravi, Maria Popp, Miriam Neidhardt, Vanessa Piechotta, Susanne Salomon, Sarah J Valk, Ina Monsef, Christoph Schmaderer, Erica M Wood, Cynthia So-Osman, David J Roberts, Zoe McQuilten, Lise J Estcourt, Nicole Skoetz

Twitter Demographics

The data shown below were collected from the profiles of 292 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 168 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 168 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 12%
Researcher 17 10%
Other 14 8%
Student > Master 12 7%
Student > Ph. D. Student 8 5%
Other 27 16%
Unknown 70 42%
Readers by discipline Count As %
Medicine and Dentistry 36 21%
Biochemistry, Genetics and Molecular Biology 12 7%
Immunology and Microbiology 8 5%
Nursing and Health Professions 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 25 15%
Unknown 73 43%

Attention Score in Context

This research output has an Altmetric Attention Score of 225. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2022.
All research outputs
#119,166
of 21,173,427 outputs
Outputs from Cochrane database of systematic reviews
#213
of 12,081 outputs
Outputs of similar age
#3,477
of 338,754 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 37 outputs
Altmetric has tracked 21,173,427 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,081 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,754 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.